Cuba initiates its mass vaccination campaign for around 1.7 million people, using its locally-developed SOBERANA 02 and ABDALA vaccines, both of which have yet to complete its Phase III clinical trials. (The New York Times) COVID-19 pandemic in Cuba, Deployment of COVID-19 vaccinesCOVID-19 pandemic in North AmericaCOVID-19 pandemic link embed save